Equities

Par Drugs and Chemicals Ltd

Par Drugs and Chemicals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)243.70
  • Today's Change9.10 / 3.88%
  • Shares traded28.96k
  • 1 Year change+32.19%
  • Beta1.0988
Data delayed at least 15 minutes, as of Sep 20 2024 11:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue956957751
OPERATING EXPENSES
Cost of revenue total338664288
Selling, general and admin. expenses, total5511141
Depreciation/amortization343233
Unusual expense(income)0--0
Other operating expenses, total3350.00259
Total operating expense763808621
Operating income194150130
Other, net2.42(1.07)1.06
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes195151127
Provision for income taxes503735
Net income after taxes14511392
Minority interest------
Net income before extra. Items14511392
Total extraordinary items------
Net income14511392
Inc.avail. to common excl. extra. Items14511392
Inc.avail. to common incl. extra. Items14511392
EPS RECONCILIATION
Basic/primary weighted average shares121212
Basic/primary eps excl. extra items129.217.49
Basic/primary eps incl. extra items129.217.49
Dilution adjustment------
Diluted weighted average shares121212
Diluted eps excl. extra items129.217.49
Diluted eps incl. extra items129.217.49
COMMON STOCK DIVIDENDS
DPS - common stock primary issue----0
Gross dividend - common stock--0--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental--0.023.74
SUPPLEMENTAL INCOME
Depreciation, supplemental343233
Total special items0(1.43)0
NORMALISED INCOME
Normalized income before taxes195149127
Effect of special items on income taxes0(0.35)0
Income tax excluding impact of special items503735
Normalized income after tax14511292
Normalized income avail. to common14511292
Basic normalized EPS129.127.49
Diluted normalized EPS129.127.49
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.